Open AccessFavorable clinical outcomes of checkpoint inhibitor-based combinations after progression with immunotherapy in advanced non-small cell lung cancer
Author(s) -
Xin Yu,
Xiangling Chu,
Yan Wu,
Juan Zhou,
Jing Zhao,
Fei Zhou,
Han Chen,
Chunxia Su
Publication year - 2021
Language(s) - English
DOI - 10.20517/cdr.2021.28
Subject(s) - medicine , oncology , immunotherapy , lung cancer , tumor progression , progression free survival , combination therapy , cancer , overall survival